Previcox Chewable Tablets for Dogs ^Rx

PREVICOX® is a veterinary prescription non-steroidal anti-inflammatory drug (NSAID) used to control pain and inflammation in dogs due to osteoarthritis (OA). NSAIDs, such as PREVICOX, improve your dog's overall mobility by relieving joint pain and inflammation.

For use in dogs.

Dogs treated with Previcox chewable tablets in dose confirmation studies showed improvement in lameness within three hours compared to untreated controls. The dogs returned to almost normal function after seven hours.

Previcox blocks the COX-2 (cyclooxygenase-2) enzyme which generates the chemicals that are responsible for fever, pain and inflammation in the body.

Boehringer Ingelheim

Firocoxib

Previcox is sold in 57 mg and 227 mg strengths in counts of 1, 10, 30, 60 or 180 chewable tablets.

The most common side effects associated with Previcox involve the digestive tract. These side effects include vomiting and decreased food consumption. Liver and kidney problems have also been reported with the use of NSAIDs. Please call your veterinarian and refer to prescribing information.

Keep away from children and animals. Consider appropriate washout times when switching from one NSAID to another or when switching from corticosteroid use to NSAID use. As a class, cyclooxygenase inhibitory NSAIDs may be associated with renal, gastrointestinal and hepatic toxicity. Sensitivity to drug-associated adverse events varies with the individual patient. Dogs that have experienced adverse reactions from one NSAID may experience adverse reactions from another NSAID. Patients at greatest risk for adverse events are those that are dehydrated, on concomitant diuretic therapy, or those with existing renal, cardiovascular, and/or hepatic dysfunction. Concurrent administration of potentially nephrotoxic drugs should be carefully approached and monitored. NSAIDs may inhibit the prostaglandins that maintain normal homeostatic function. Such anti-prostaglandin effects may result in clinically significant disease in patients with underlying or pre-existing disease that has not been previously diagnosed. Since NSAIDs possess the potential to produce gastrointestinal ulceration and/or gastrointestinal perforation, concomitant use of PREVICOX Chewable Tablets with other anti-inflammatory drugs, such as NSAIDs or corticosteroids, should be avoided. The concomitant use of protein-bound drugs with PREVICOX Chewable Tablets has not been studied in dogs. Commonly used protein-bound drugs include cardiac, anticonvulsant, and behavioral medications. The influence of concomitant drugs that may inhibit the metabolism of PREVICOX Chewable Tablets has not been evaluated. Drug compatibility should be monitored in patients requiring adjunctive therapy. If additional pain medication is needed after the daily dose of PREVICOX, a non-NSAID class of analgesic may be necessary. Appropriate monitoring procedures should be employed during all surgical procedures. Anesthetic drugs may affect renal perfusion, approach concomitant use of anesthetics and NSAIDs cautiously. The use of parenteral fluids during surgery should be considered to decrease potential renal complications when using NSAIDs perioperatively. The safe use of PREVICOX Chewable Tablets in pregnant, lactating or breeding dogs has not been evaluated.

In case of overdose, contact your veterinarian or nearest emergency animal clinic.

Store at room temperature between 59° - 86°F. Brief periods up to 104°F are permitted.